Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma

Zhao Lijun, Lijun Zhao, Zhao Xin, Xin Zhao, Shen Danhua, Li Xiaoping, Xiaoping Li, Wang Jianliu, Jianliu Wang, Huilan Wang, Wang Huilan, Wei Lihui
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2012 · vol. 22(5) , pp. 836–841 · doi:10.1097/igc.0b013e31825401c6 · PMID:22617481 · W2319765809
Observational OA: closed CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-14 ⓘ

This study investigated the prognostic significance of tumor-infiltrating dendritic cells in endometrial carcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To investigate the distribution of dendritic cells (DCs) at different development status in endometrial carcinoma and their relationship with clinical pathology. METHODS: Samples were collected from 95 patients with endometrial endometrioid adenocarcinoma treated in Peking University People's Hospital from 2002 to 2010. Normal endometrial tissue was obtained from 40 women and served as controls. Immunohistochemistry was used to detect the expression of S100-, human leukocyte antigen (HLA)-DR-, and CD1a-positive DCs within the tumor glandular epithelium, the surrounding tumor interstitial tissue, and the equivalent normal endometrial tissue. The relationship of these DCs with clinical stage, pathology grade, myometrial invasion, and lymph node metastasis was analyzed. RESULTS: The rate of S100-positive DCs in the endometrial endometrioid adenocarcinoma glandular epithelium samples from the 95 patients was 48.4% (46/95), and that of the HLA-DR-positive DCs was 27.4% (26/95), which were both significantly higher (P < 0.05) than that in the control group. CD1a-positive DC was rarely expressed in endometrial endometrioid adenocarcinoma glandular epithelium. The rates of the S100- and HLA-DR-positive DCs in tumor interstitial tissue were similar to that of the control group (both, P > 0.05). The proportion of invasion of the S100- and HLA-DR-positive DCs was negatively correlated with the clinical stage and lymph node metastasis but was not correlated with the pathological grade and myometrial invasion. CONCLUSIONS: Dendritic cell invasion was detected in endometrial endometrioid adenocarcinoma. S100- and HLA-DR-positive DCs may have functions related to the delay of tumor progression and lymph node metastasis.

My notes (saved in your browser only)

MeSH descriptors

Carcinoma, Endometrioid Dendritic Cells Dendritic Cells Endometrial Neoplasms Endometrium Myometrium Adult Aged Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Case-Control Studies Dendritic Cells Dendritic Cells Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Endometrium Endometrium Endometrium

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (20)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:10:20.980095+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK